Neurology

Genetic variant regulates response to leading multiple sclerosis therapy.

Unbalanced gut bacteria can lead to autoimmune disorders such as type 1 diabetes, rheumatoid arthritis, and multiple sclerosis.

Drugs that activate nervous system stem cells may cause formation of new myelin.

Favorable evidence supports the drug's utility in certain psychiatric and neurological disorders.

Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses the elements of an optimal program for monitoring patients with multiple sclerosis to ensure adherence.

Miconazole and clobetasol may play a role in helping cells produce myelin.

Blocking production of specific immune cell protects against onset of MS.

Two new drugs showed significant reversal of disease severity.

Long term implications result when patients stop taking disease-modifying drugs.

Topical medications that treat skin conditions prompt stem cells in the brain to repair damage.

Pushing treatment with natalizumab from 4 weeks up to 8 weeks shows promising results.

Medication also used in treatment of Crohn's disease effective at blocking pathways.

Phenytoin helps to reduce damage to the nerve fiber.

The FDA today expanded the indication of Allergan's onabotulinumtoxinA (Botox), allowing the drug to be used for the treatment of upper limb spasticity in adults.

Researchers find biological evidence of repaired myelin.

New drug is the first approved generic of Copaxone.

The FDA today approved Sandoz's glatiramer acetate (Glatopa), a once-daily injection indicated for relapsing forms of multiple sclerosis.

Increased neuron activity helps to protect nerve fibers.

Energy drink overconsumption has dangerous cardiac and neurologic consequences in adolescents.

Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses methods specialty pharmacies can use to enhance adherence in patients with multiple sclerosis.

Procedure may be more effective than leading drug mitoxantrone.

Shire's ADHD treatment, lisdexamfetamine dimesylate (Vyvanse), is now available in a 10-mg titration dose.

Epilepsy has scores of factors, each leading to different treatment strategies and complicating the development of an evidence-based approach to seizure control.

Newly characterized compounds found to block inflammation and nerve cell damage.